International Network of VENous Thromboembolism Clinical Research Networks

Dose-Adjusted Apixaban

A Clinical Trial of Dose-Adjusted Apixaban In CancerPatients with Thrombocytopenia and Venous Thromboembolism


Beth Israel Deaconess Medical Center, USA


Single arm prospective cohort study of dose-adjusted apixaban in 30 patients with active malignancy and acute VTE.

Participating Sites

VENUS logo

Lead Network:

Flag of USA


The Netherlands, USA,

Lead Investigators

Mandy Lauw, MD PhD

Erasmus University Rotterdam, the Netherlands.

Rushad Patell, MD

Harvard University, USA.


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.